RxDoctor Payments Data

James Mazur, DPM

Primary Podiatric Medicine · Salisbury, NCNPI 1649275843

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 38.7% of the total. Reporting peaked in 2019 at $224 and has fallen 67.6% since, to $73 in 2024. That places this record below the midpoint for primary podiatric medicine clinicians in NC, where the typical reported total is $1,305.

$641in general payments, 2019–2025

Across 25 payments — averaging $25.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$248
  • Melinta Therapeutics, LLC$42
  • Merck$38
  • GRT US Holding, Inc.$37
  • Convatec Inc.$34
  • Paratek Pharmaceuticals, Inc.$26
  • plus $217 from 13 others

What the payments were for

  • Food & beverage$641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$641 in reported general payments places this provider in the 30th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,941
Medicare patients
142
Services billed
397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin117$1,002
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$128
Cephalexin22$115

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →